Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma

NCT01367002 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01367002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01367002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in HER2/Neu+ Patients With Advance/Recurrent Uterine Serous Papillary Carcinoma
Lead sponsor
Yale University
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2022
Enrollment
61 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer